Atectura

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atectura, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®